Psychiatric Quarterly

, Volume 66, Issue 1, pp 87–95

Bromocriptine and psychosis: A literature review

Authors

  • Alan Boyd
    • Tulane Medical Center, Department of Psychiatry and NeurologyTulane University
Articles

DOI: 10.1007/BF02238717

Cite this article as:
Boyd, A. Psych Quart (1995) 66: 87. doi:10.1007/BF02238717

Abstract

Bromocriptine is an ergot-derived dopamine agonist. Its current uses include the treatment of Parkinson's disease, postpartum ablaction, prolactionmas, acromegaly, and amenorrhea and galactorrhea secondary to neuroleptic use. It is often reported to produce psychiatric side effects such as confusion, hallucinations, and delusions. The literature is reviewed and supports a strong anecdotal relationship between bromocriptine use and psychosis.

Copyright information

© Human Sciences Press, Inc. 1995